American Cancer Society. www.cancer.org/downloads/PRO/OralCancer.pdf.
2
0026751470
Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity
Jones KR, Lodge-Rigal RD, Reddick RL, et al. Prognostic factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch Otolaryngol Head Neck Surg 1992;118(5):483-485.
Photodynamic therapy in the treatment of multiple primary tumors in the head and neck, located to the oral cavity and oropharynx
Copper MP, Triesscheijn M, Tan IB, et al. Photodynamic therapy in the treatment of multiple primary tumors in the head and neck, located to the oral cavity and oropharynx. Clin Otolaryngol 2007;32(3):185-189.
PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies
Schweitzer VG. PHOTOFRIN-mediated photodynamic therapy for treatment of early stage oral cavity and laryngeal malignancies. Lasers Surg Med 2001;29:305-313.
Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity
Fan KFM, Hopper C, Speight PM, et al. Photodynamic therapy using 5-aminolevulinic acid for premalignant and malignant lesions of the oral cavity. Cancer 1996;78(7):1374-1383.
Meta-tetra(hydroxyphenyl) chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck
Copper MP, Tan IB, Oppelaar H, et al. Meta-tetra(hydroxyphenyl) chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2003;129(7):709-711.